相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice
Lautaro Zubeldia-Brenner et al.
ENDOCRINE-RELATED CANCER (2019)
Acromegaly
Annamaria Colao et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Medical therapy for non-functioning pituitary tumors-a critical approach
Metaxia Tampourlou et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2019)
Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression
Bing Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Prognostic factors of regrowth in nonfunctioning pituitary tumors
Gerald Raverot et al.
PITUITARY (2018)
The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes
Matthew P. Salomon et al.
CLINICAL CANCER RESEARCH (2018)
Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors
Mahalakshmi Ramadoss et al.
DRUG DISCOVERY TODAY (2018)
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
Xiangyi Li et al.
CELL REPORTS (2018)
BET Bromodomain Inhibition Cooperates with PD-1 Blockade to Facilitate Antitumor Response in Kras-Mutant Non-Small Cell Lung Cancer
Dennis O. Adeegbe et al.
CANCER IMMUNOLOGY RESEARCH (2018)
BRD4 and Cancer: going beyond transcriptional regulation
Benedetta Donati et al.
MOLECULAR CANCER (2018)
Giant pituitary adenoma: histological types, clinical features and therapeutic approaches
Pedro Iglesias et al.
ENDOCRINE (2018)
Landscape of Genomic Alterations in Pituitary Adenomas
Wenya Linda Bi et al.
CLINICAL CANCER RESEARCH (2017)
Management of aggressive growth hormone secreting pituitary adenomas
Daniel A. Donoho et al.
PITUITARY (2017)
Diagnosis and Treatment of Pituitary Adenomas A Review
Mark E. Molitch
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Discovery of novel trimethoxy-ring BRD4 bromodomain inhibitors: AlphaScreen assay, crystallography and cell-based assay
Zhifeng Chen et al.
MEDCHEMCOMM (2017)
Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine
Christoph J. Schankin et al.
BRAIN (2016)
Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
Kjell Oberg et al.
ENDOCRINE-RELATED CANCER (2016)
Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy
Elias E. Stratikopoulos et al.
CANCER CELL (2015)
Recurrent gain-of-function USP8 mutations in Cushing's disease
Zeng-Yi Ma et al.
CELL RESEARCH (2015)
Binding Kinetics versus Affinities in BRD4 Inhibition
Ming Kuang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Management of medically refractory prolactinoma
Mark E. Molitch
JOURNAL OF NEURO-ONCOLOGY (2014)
Epidemiology and etiopathogenesis of pituitary adenomas
Elena D. Aflorei et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells
Warren Fiskus et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Aggressive pituitary adenomas-diagnosis and emerging treatments
Antonio Di Ieva et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
MYC Regulation of CHK1 and CHK2 Promotes Radioresistance in a Stem Cell-like Population of Nasopharyngeal Carcinoma Cells
Wen-Jun Wang et al.
CANCER RESEARCH (2013)
BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy
Miguel F. Segura et al.
CANCER RESEARCH (2013)
Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma
Zhixiang Cheng et al.
CLINICAL CANCER RESEARCH (2013)
Two faces of BRD4 Mitotic bookmark and transcriptional lynchpin
Ballachanda N. Devaiah et al.
TRANSCRIPTION-AUSTIN (2013)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Expression and Clinical Significance of Wnt Players and Survivin in Pituitary Tumours
Robert Formosa et al.
ENDOCRINE PATHOLOGY (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Tumor Cell Kill by c-MYC Depletion: Role of MYC-Regulated Genes that Control DNA Double-Strand Break Repair
Kaisa R. Luoto et al.
CANCER RESEARCH (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Pathology of the human pituitary adenomas
Robert Y. Osamura et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Proliferative potential after DNA damage and non-homologous end joining are affected by loss of securin
J. A. Bernal et al.
CELL DEATH AND DIFFERENTIATION (2008)
Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth
Vera Chesnokova et al.
CANCER RESEARCH (2007)
The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation
Shwu-Yuan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein brd4
ZY Yang et al.
MOLECULAR CELL (2005)
Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour
HE Turner et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
